Rafferty Asset Management
BPMC

Rafferty Asset Management’s Blueprint Medicines BPMC Stock Holding History

Rafferty Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-60,567
Closed -$7.76M – 1110
2025
Q2 		$7.76M Sell
60,567
-38,753
-39% -$4.03M 0.03% 318
2025
Q1 		$8.79M Buy
99,320
+10,429
+12% +$1.02M 0.04% 279
2024
Q4 		$7.75M Sell
88,891
-28,133
-24% -$2.58M 0.03% 327
2024
Q3 		$10.8M Buy
117,024
+22,061
+23% +$2.19M 0.04% 275
2024
Q2 		$10.2M Sell
94,963
-4,388
-4% -$439K 0.04% 276
2024
Q1 		$9.42M Sell
99,351
-22,017
-18% -$1.89M 0.04% 283
2023
Q4 		$11.2M Sell
121,368
-45,322
-27% -$2.94M 0.05% 241
2023
Q3 		$8.37M Buy
166,690
+24,693
+17% +$1.32M 0.05% 270
2023
Q2 		$8.97M Sell
141,997
-19,893
-12% -$1.08M 0.05% 230
2023
Q1 		$7.28M Sell
161,890
-8,792
-5% -$396K 0.05% 278
2022
Q4 		$7.48M Buy
170,682
+79,592
+87% +$3.82M 0.06% 280
2022
Q3 		$6M Buy
91,090
+11,687
+15% +$751K 0.06% 292
2022
Q2 		$4.01M Sell
79,403
-14,232
-15% -$834K 0.04% 327
2022
Q1 		$5.98M Buy
93,635
+39,214
+72% +$2.81M 0.04% 331
2021
Q4 		$5.83M Buy
54,421
+22,836
+72% +$2.39M 0.03% 318
2021
Q3 		$3.25M Buy
31,585
+1,571
+5% +$146K 0.02% 430
2021
Q2 		$2.64M Sell
30,014
-1,033
-3% -$94.7K 0.02% 560
2021
Q1 		$3.02M Buy
31,047
+22,919
+282% +$2.29M 0.02% 489
2020
Q4 		$912K Sell
8,128
-21,730
-73% -$2.29M 0.01% 529
2020
Q3 		$2.77M Buy
29,858
+16,194
+119% +$1.25M 0.03% 331
2020
Q2 		$1.07M Buy
13,664
+8,309
+155% +$562K 0.02% 524
2020
Q1 		$313K Sell
5,355
-40,170
-88% -$2.58M 0.01% 426
2019
Q4 		$3.65M Sell
45,525
-36,595
-45% -$2.74M 0.06% 188
2019
Q3 		$6.03M Buy
82,120
+27,608
+51% +$2.39M 0.09% 126
2019
Q2 		$5.14M Buy
54,512
+18,182
+50% +$1.5M 0.09% 158
2019
Q1 		$2.91M Buy
+36,330
New +$2.68M 0.05% 226

Other funds holding BPMC

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Rafferty Asset Management's BPMC Position: Q3 2025 in Review

Rafferty Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 60,567 shares — an estimated $7.76M sold.

Rafferty Asset Management first reported a position in BPMC in Q1 2019 and held it in 26 quarters. The position peaked at $11.2M in Q4 2023. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

  • Rafferty Asset Management reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
  • Rafferty Asset Management sold 60,567 Blueprint Medicines shares in Q3 2025, an estimated $7.76M.
  • Rafferty Asset Management first reported a position in Blueprint Medicines in Q1 2019 and held it in 26 quarters.
  • Rafferty Asset Management's Blueprint Medicines position peaked at $11.2M in Q4 2023.
  • 5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Rafferty Asset Management's 13F filing for Q3 2025, filed 12 Nov 2025.